跳至主要内容
临床试验/NCT01797133
NCT01797133已完成不适用

A Comparative Study of ID Fellow-based Pre-authorization VS. Pharmacist-based Pre-authorization in Reducing Antibiotic Consumptions and Hospital Expenditures

Siriraj Hospital1 个研究点 分布在 1 个国家目标入组 984 人开始时间: 2013年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
984
试验地点
1
主要终点
Defined Daily Dose (DDD) of antibiotics

研究概览

简要总结

We will conduct a cluster randomized controlled trial to compare two antibiotic pre-authorization strategies (Fellow-based vs. Pharmacist-based). We believe that amount and duration of antibiotic consumption would be lower in the pharmacist group while the clinical outcome would be equivalent between two groups.

详细描述

Study design: A cluster randomized controlled trial Settings: 6 general medical wards at Siriraj Hospital, Bangkok, Thailand

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Hospitalized patients
  • •Received at least one dose of controlled antibiotics (Piperacillin/Tazobactam, Imipenem/Cilastatin, Meropenem or Doripenem)
  • •Each patient may be enrolled more than once, if he/she receives the controlled antibiotic for a new episode of infection (at least 48 hour apart)

排除标准

  • •Died prior to receive the controlled antibiotic

研究组 & 干预措施

Fellow arm

Active Comparator

Patients in this arm will receive the ID fellow-based antibiotic pre-authorization intervention.

干预措施: ID fellow-based antibiotic pre-authorization (Procedure)

Pharmacist arm

Active Comparator

Patients in this arm will receive the pharmacist-based antibiotic pre-authorization intervention.

干预措施: Pharmacist-based antibiotic pre-authorization (Procedure)

结局指标

主要结局

Defined Daily Dose (DDD) of antibiotics

时间窗: Participants will be followed for the total duration of antibiotic therapy for that given infection, an expected average of 2 weeks

DDD of antibiotic use for that given infection (all antibiotics and controlled antibiotics)

次要结局

  • Total duration of antibiotic use(Participants will be followed for the total duration of antibiotic therapy for that given infection, an expected average of 2 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pinyo Rattanaumpawan

Asssitant Professor

Siriraj Hospital

研究点 (1)

Loading locations...

相似试验